Entry Point Capital, LLC Sera Prognostics, Inc. Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SERA
# of Institutions
73Shares Held
19.8MCall Options Held
35.4KPut Options Held
0-
Baker Bros. Advisors LP New York, NY5.43MShares$36.6 Million0.43% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$20.4 Million0.27% of portfolio
-
Interwest Venture Management CO2.42MShares$16.3 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$11.1 Million1.44% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$9.5 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $199M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...